[1] 中华医学会皮肤性病学分会免疫学组,特应性皮炎协作研究中心.中国特应性皮炎诊疗指南(2020版)[J].中华皮肤科杂志,2020,53(2):81-88.
[2] 顾恒,尤立平,刘永生,等.我国10城市学龄前儿童特应性皮炎现况调查[J].中华皮肤科杂志, 2004,37(1):29-31.
[3] GUO Y F, LI P, TANG J P, et al. Prevalence of atopic dermatitis in Chinese children aged 1-7 ys[J].Sci Rep, 2016, 6:29751. DOI:10.1038/srep29751.
[4] GUO Y, ZHANG H, LIU Q, et al. Phenotypic analysis of atopic dermatitis in children aged 1-12 months:elaboration of novel diagnostic criteria for infants in China and estimation of prevalence[J].J Eur Acad Dermatol Venereol, 2019, 33(8):1569-1576.
[5] CZERUCKA D, RAMPAL P. Experimental effects of saccharomyces boulardii on diarrheal pathogens[J]. Microbes Infect, 2002, 4(7):733-739.
[6] PLAZA-DIAZ J, RUIZ-OJEDA FJ, GIL-CAMPOS M, et al. Mechanisms of action of probiotics[J].Adv Nutr, 2019, 10:S49-S66. DOI:10.1093/advances/nmy063.
[7] WANG M, KARLSSON C, OLSSON C, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema[J].J Allergy Clin Immunol, 2008, 121(1):129-134.
[8] BISGAARD H, LI N, BONNELYKKE K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age[J]. J Allergy Clin Immunol, 2011, 128(3):646-52.el-5.
[9] CHEN C F, WU K G, HSU M C, et al. Prevalence and relationship between allergic diseases and infectious diseases[J]. J Microbiol Immunol Infect, 2001, 34(1):57-62.
[10] SILVERBERG J I, SIMPSON E L. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization[J].Pediatr Allergy Immunol, 2013, 24(5):476-486.
[11] BOHME M, LANNERO E, WICKMAN M, et al. Atopic dermatitis and concomitant disease patterns in children up to two years of age[J].Acta Derm Venereol, 2002, 82(2):98-103.
[12] CASTAGLIUOLO I, RIEGLER M F, VALENICK L, et al. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa[J].Infect Immun, 1999, 67(1):302-307.
[13] CHEIKHYOUSSEF A, CHEIKHYOUSSEF N, CHEN H, et al.Bifidin I-A new bacteriocin produced by Bifidobacterium infantis BCRC 14602:Purification and partial amino acid sequence[J]. Food Conrtol, 2010, 21(5):746-753
[14] Jiang H, ZOU J, CHENG H,et al. Purification, characterization, and mode of cation of pentocin JL-1, a novel bacteriocin isolated from Lactobacillus pentosus, against drug-resistant Staphylococcus aureus[J]. Biomed Res Int,2017, 2017(2):1-11.
[15] DE MARCO S, SICHETTI M, MURADYAN D, et al. Probiotic cell-free supernatants exhibited anti-inflammatory and antioxidant activity on human gut epithelial cells and macrophages stimulated with LPS[J].Evid Based Complement Alternat Med, 2018, 2018:1756308. DOI:10.1155/2018/1756308.
[16] OFFEI B, VANDECRUYS P, DE G S, et al. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast Saccharomyces cerevisiae var. boulardii[J].Genome Res,2019, 29(9):1478-1494.
[17] SCHIAVI E, GLEINSER M, MOLLOY E, et al. The Surface-associated exopolysaccharide of Bifidobacterium longum 35624 plays an essential role in dampening host proinflammatory responses and repressing local TH17 responses[J]. Appl Environ Microbiol,2016, 82(24):7185-7196.
[18] SCHIAVI E, PLATTNER S, RODRIGUEZ-PEREZ N, et al. Exopolysaccharide from Bifidobacterium longum subsp. longum 35624TM modulates murine allergic airway responses[J]. Benef Microbes, 2018, 9(5):761-773.
[19] KUNYEIT L, KURREY N K, ANU-APPAIAH K A, et al. Probiotic yeasts inhibit virulence of non-albicans Candida species[J]. mBio,2019, 10(5):e02307-19.
[20] MARTINS F S, DALMASSO G, ARANTES R M, et al. Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection[J].PLoS One, 2010, 5(1):e8925.
[21] PERDIGON G, ALVAREZ S, PESCE DE RUIZ HOLGADO A.Immunoadjuvant activity of oral Lactobacillus casei:influence of dose on the secretory immune response and protective capacity in intestinal infections[J]. J Dairy Res,1991, 58(4):485-496.
[22] FIDAN I, KALKANCI A, YESILYURT E, et al. Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans[J]. Mycoses, 2009, 52(1):29-34.
[23] RAJPUT I R, HUSSAIN A, LI Y L, et al. Saccharomyces boulardii and Bacillus subtilis B10 modulate TLRs mediated signaling to induce immunity by chicken BMDCs[J]. J Cell Biochem, 2014, 115(1):189-198.
[24] ASHRAF R, SHAH N P. Immune system stimulation by probiotic microorganisms[J]. Crit Rev Food Sci Nutr, 2014, 54(7):938-956.
[25] FLOCH M H, WALKER W A, SANDERS M E, et al. Recommendations for probiotic use-2015 update:proceedings and consensus opinion[J]. J Clin Gastroenterol, 2015, 49(Suppl 1):S69-S73.
[26] SHARMA G, IM S H.Probiotics as a potential immunomodulating pharmabiotics in allergic disease:current status and future prospects[J]. Allergy Asthma Immunol Res, 2018, 10(6):575-590.
[27] YESILOVA Y,ÇALKAÖ, AKDENIZ N, BERKTAS M. Effect of probiotics on the treatment of children with atopic dermatitis[J]. Ann Dermatol,2012, 24(2):189-193.
[28] PANDURU M, PANDURU N M, SALAVASTRU C M, et al. Probiotics and primary prevention of atopic dermatitis:a meta-analysis of randomized controlled studies[J]. J Eur Acad Dermatol Venereol, 2015, 29(2):232-242.
[29] 周光中.布拉氏酵母菌佐治婴儿湿疹的临床观察[J].黑龙江医学,2015,39(2):187-189.
[30] 许善玲,陈东亮,钟健,等.布拉氏酵母菌散佐治湿疹患儿的临床效果及对肠道菌群的影响[J].医疗装备,2018,31(23):90-91.
[31] 官正进,林敏.布拉氏酵母菌联合左西替利嗪治疗小儿特应性皮炎的临床疗效及安全性评价[J].中国微生态学杂志,2016,28(5):561-563. |
